VECTOR BIOMED INC.

VECTOR BIOMED INC. specializes in the GMP-compliant manufacturing and stability testing of clinical-grade lentiviral vectors for use in gene therapy and oncology research. The company provides end-to-end process development and production services for complex biological products, with demonstrated expertise in viral vector purification, characterization, and cryopreservation under strict regulatory frameworks. Their technical capabilities include scalable upstream and downstream processing, vector titration, transduction efficiency validation, and long-term stability studies—critical for advancing cell and gene therapies in preclinical and early-phase clinical settings. A key differentiator is their focus on lentiviral platforms for pediatric oncology applications, supporting high-purity, clinically translatable products under NIH-sponsored programs. VECTOR BIOMED INC. maintains a consistent partnership with the Department of Health and Human Services, particularly through the National Institutes of Health’s National Cancer Institute and its Pediatric Oncology Branch. The contractor delivers specialized biological manufacturing services tailored to mission-critical cancer research initiatives, indicating a trusted, mission-aligned relationship centered on the production of investigational lentiviral therapeutics such as CX170. This sustained engagement reflects a deep understanding of NCI’s translational research needs and regulatory expectations for investigational biological products. The company’s primary industry focus is Biological Product (Except Diagnostic) Manufacturing (NAICS 325414), positioning it within the advanced therapeutics sector. It serves the growing demand for ex vivo gene-modified cell therapies, particularly those requiring lentiviral transduction systems for targeted delivery of therapeutic genes. The firm operates at the intersection of biopharmaceutical manufacturing and academic research, supporting next-generation oncology treatments with scalable, GMP-aligned production infrastructure. As a small business structured as a 2L entity based in Gaithersburg, Maryland, VECTOR BIOMED INC. leverages its proximity to federal research hubs and biotech ecosystems to support federal biomedical initiatives. While currently holding no formal government certifications, its operational compliance with cGMP standards and direct engagement with NIH programs underscores its credibility in the federal biomanufacturing landscape.